Company: IMCR
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012123
Chunk: 120

Company: Immunocore Holdings plc
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 120
---
 price is equal to the market value of the shares on the date of the grant and therefore there is no value to disclose. Details of awards granted and held are set out in the options table further below in this report. There were no performance obligations linked to the share-based awards granted during the years above. |

| 4. | Robert Perez and Travis Coy were originally nominated to our board of directors by General Atlantic and Eli Lilly S.A., respectively, pursuant to our pre-IPO fundraising arrangements, which granted a right to each of General Atlantic and Eli Lilly S.A. to appoint an individual to our board. Both directors elected to forgo remuneration in respect of their services as non-executive directors. |

2024 Annual Bonus In 2024, the CEO’s bonus of $573,750 (being 75% of salary), compared to $606,375 (82.5% of salary) in 2023, was based on corporate, strategic objectives: Lead in T cell receptor (“TCR”) Innovation (50%); Grow the Business (40%); Be the Best Workplace (10%), measured through the annual bonus scorecard. The summary of our 2024 annual performance bonus design below includes the level of detail we believe we can disclose without creating competitive harm for the Company.

| Metric                           |     | Weight |     | Goals                                                                                                                                                                                                                |     | Achievement |     | Weighted    
 Achievement |
| Lead in TCR Innovation           |     | 50%    |     | Goals focused on executing our clinical trials, building our pipeline for new products, completing regulatory submissions, high impact publications and other related matters                                        |     | 95.2%       |     | 47.6%       |
| Grow the Business                |     | 40%    |     | Goals pertaining to commercial and other matters, including related to expanding access to our product, governmental affairs, sales, cash and operating expense targets, investor relations and business development |     | 103.5%      |     | 41.4%       |
| Be the Best Workplace            |     | 10%    |     | Goals related to recruiting, employee engagement, compliance, workforce planning, culture and other employee matters                                                                                                 |     | 108.0%      |     | 10.8%       |
| Initial Calculated Achievement   |     |        |     |                                                                                                                                                                                                                      |     |             |     | 99.8%       |
| Adjusted Achievement (See Below) |